Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain

Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), an infectious coronavirus first reported in 2012, has a mortality rate greater than 35%. Therapeutic antibodies are key tools for preventing and treating MERS-CoV infection, but to date no such agents have been approved for treatment of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Viruses
Main Authors: He, Lei, Tai, Wanbo, Li, Jiangfan, Chen, Yuehong, Gao, Yaning, Li, Junfeng, Sun, Shihui, Zhou, Yusen, Du, Lanying, Zhao, Guangyu
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410414/
https://ncbi.nlm.nih.gov/pubmed/30791410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11020166
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados